Researcher

Xue Zhang

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 26, 2026 · JOURNAL ARTICLE

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International Journal of Pharmaceutics: X

A comprehensive review synthesizing current knowledge on biomaterial-based drug delivery for head and neck cancer, identifying clinical challenges and therapeutic opportunities without presenting original experimental data or clinical trial results.

Expert GuidanceJunxiong Wen Combination Therapy Xiao Cui

Reported

HNSCC and OSCC proportion of HNCapproximately 90%

5-year survival rate for advanced…50–60%

JUN 15, 2026 · JOURNAL ARTICLE

Multi-targeted biomimetic CeO₂-based nanoplatform for sepsis therapy via mitochondrial homeostasis.

International Journal of Pharmaceutics: X

This is an early-stage preclinical study demonstrating a novel nanoplatform in a mouse sepsis model with in vitro validation, lacking human clinical data and requiring confirmation in larger studies before clinical translation.

PreliminaryYuan Tan Sepsis Treatment Yao Li

Study details

DesignPreclinical in vitro and animal model study

InterventionIC@CeO₂@MM nanoplatform (cerium dioxide nan…